Aperio Raises $10.6 Million in Venture Capital Funding

Aperio Technologies, Inc., the leading provider of digital pathology systems and services to the healthcare and life sciences industry, announced recently that it has closed a $10.6 million round of financing. Aperio will use the new capital to further expand its sales, marketing and operations efforts, develop new products, and implement its clinical market strategy. To date, the company has raised a total of $33 million in equity capital.

The round was co-led by Galen Partners, a Stamford, Connecticut-based private equity firm specializing in healthcare investing, and Advanced Technology Ventures (ATV) a bi-coastal venture fund specializing in healthcare and technology investments. Other existing investors also participated. Terms of the financing deal were not disclosed.

“As the recognized leader in digital pathology, with an installed base of more than 250 systems in more than 23 countries, and customers that include half of the top 13 pharmaceutical companies and more than two-thirds of the top 14 rated U.S. hospitals, Aperio is well-positioned to unlock this market,” said Tom Rodgers, a principal at Advanced Technology Ventures and a former vice president of corporate strategy at McKesson. “Based on the benefits derived by the existing customer base, including increased efficiency, cost savings, and improved patient care, we believe Aperio will continue to dominate and lead this space with its pivotal technology.”

Dirk Soenksen, CEO of Aperio added,“The additional capital investment by our existing investor team is an exceptional vote of confidence in Aperio and its technology. We have benefited greatly from their proven experience in building healthcare technology companies and look forward to continuing to lead the industry in the adoption of digital pathology.”

Zubeen Shroff, general partner at Galen, commented that, “Aperio has done a terrific job in scaling its operations to address increasing customer demand. They have solidified their leadership position in this rapidly emerging market by having superior products, successful go-to-market strategies, and being relentless in their focus on customer’s unmet needs.”

Aperio provides systems and services for digital pathology. Our award-winning ScanScope slide scanning systems and Spectrum digital pathology information management software is helping pathology professionals around the world improve the efficiency and quality of pathology services, enhance patient care, and improve the bottom line. Applications include remote viewing, archival and retrieval, digital conferencing, research and education, and image analysis.

For more information, please visit www.aperio.com